Quantification of free ligand conformational preferences by NMR and their relationship to the bioactive conformation

Impact

  1. C4X Discovery: generating market-leading drug candidates from cutting-edge technology

    Andrew Almond (Participant) & Charles Blundell (Participant)

    Impact: Economic, Technological

  2. Opening the door to ligand-based drug discovery: a rapid and accurate technology for determining bioactive 3D molecular shapes

    Andrew Almond (Participant) & Charles Blundell (Participant)

    Impact: Economic impacts, Health impacts, Technological impacts

Return to publication overview